Csizmar CM, Natu A, Gurney M, Fathima S, et al. Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes. Leukemia 2025 Jun 24. doi: 10.1038/s41375-025-02648.
PMID: 40555734